Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape
about
B7-H5 costimulates human T cells via CD28HSafety, activity, and immune correlates of anti-PD-1 antibody in cancerPD-L1 expression in human cancers and its association with clinical outcomesTowards tumor immunodiagnosticsA Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune CheckpointsThe efficacy and potential predictive factors of PD-1/PD-L1 blockades in epithelial carcinoma patients: a systematic review and meta analysisNK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Immunotherapy for cancer in the central nervous system: Current and future directionsEpstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune ResponseImmunotherapy for lung cancerClinical utility of nivolumab in the treatment of advanced melanomaThe effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune responseAdvances in immunotherapy for melanomaPD-1/PD-L1 blockade in cancer treatment: perspectives and issuesPredictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysisChinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic ApproachesViro-immune therapy: A new strategy for treatment of pancreatic cancerExercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and ProgressionPredictive factors for immunotherapy in melanomaImmunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigationsNew developments in the management of advanced melanoma - role of pembrolizumabThe Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor MicroenvironmentAntagonists of PD-1 and PD-L1 in Cancer TreatmentDevelopment of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung CancerMelanoma: From Incurable Beast to a Curable Bet. The Success of ImmunotherapyAdaptive Immune Resistance: How Cancer Protects from Immune AttackReflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune ResponseUnderstanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpointsAcquired and intrinsic resistance in cancer immunotherapyThe programmed death-1 immune-suppressive pathway: barrier to antitumor immunityImmunotherapy for prostate cancer: recent developments and future challengesPD-1 as an emerging therapeutic target in renal cell carcinoma: current evidenceImmunotherapy advances for glioblastomaImmunotherapy in the treatment of non-small cell lung cancerInnate and adaptive immune cells in the tumor microenvironmentThe STING pathway and the T cell-inflamed tumor microenvironmentNew immunotherapies targeting the PD-1 pathwayImmunotherapy for brain cancer: recent progress and future promiseIndividualising treatment choices in a crowded treatment algorithm
P2860
Q24295841-DC50CF09-5B60-4587-B307-AFB5B9984D45Q24633070-7B2C7B5D-C982-4D13-ADB6-3600273E2070Q26738361-C8A581FA-6980-4868-B21E-C6806FA6496DQ26738691-1ED92FD2-B07E-46CB-8345-888D8C600EFAQ26738729-780C4885-BA17-4383-A28F-5172688003D1Q26740280-467AAD94-F830-436D-B794-29CB63C11480Q26746478-58A471EF-6264-4639-926A-0E02BC56FAAAQ26750765-590E9397-FFF3-45F4-B773-435A95E1ACE7Q26751029-F37921D0-3E3D-4996-8B0E-79C9EBA04CC2Q26751254-F63E865F-8E5F-47F7-8B6B-E3F6F41B55A2Q26751268-1A6E25B3-CCF7-48C9-B725-B2BA9B797252Q26766066-4E3BDA06-20C3-457A-A1F1-254ABA35E7CCQ26768558-AA166346-D327-4EA1-BB86-E02BB9F00E2AQ26768641-F79C23D6-A2AD-4A62-8BE8-BCC21AC19C0BQ26769728-663D6FB2-C36D-4DA2-9F7F-A526D246DFCFQ26770492-2D7DFCF4-15BD-4B41-BF3D-5A298E205712Q26774312-8BD4DDFC-87CD-4A3B-B962-C84FBAC718CFQ26774641-77586676-18D0-4A0B-8143-53CC4C2D1D04Q26775189-1CD98F73-04A5-4F68-AC2A-B112570128D7Q26778765-A52F1FB7-E201-4854-90ED-690C9FE19F10Q26781038-A2E86946-196F-4D0E-BDA8-C117555E78CCQ26781931-504E1F87-897C-4380-9CDC-E7CCBBF102BAQ26796305-1B1C1E30-CA66-47C6-9CD3-71B3E6950EB9Q26796311-F7933698-03A2-4E48-8FE3-116F4ED4B1C9Q26798047-B11CC056-6B3A-4FC4-8922-989E37BD4452Q26798404-B5AEFD52-8BD4-4886-8A9C-9E786D27AFD6Q26798448-FF546BB7-6AB0-4D76-88B2-7934ED757972Q26799073-26EDA60E-3C8E-4FB5-AD02-8C868B13B328Q26801551-4F5D22BF-331C-4B49-AD5A-F2065074DCAEQ26827701-10741874-A923-4727-8A2D-6693FC12783AQ26829847-8F61CBF0-E84C-45A5-94AD-0E61B5389133Q26852388-3D9EFFDF-1DB2-4992-B2EE-CDDF8D94DABEQ26865789-F56BA7AB-EF13-4A92-8AAB-BE302CBE8EDBQ26866513-342BF986-57EC-4CED-A149-E9CFA854B73FQ27000382-B2069538-E853-4202-91F4-74F44AF62197Q27008342-8645DA03-8DA7-4EFA-A52A-999BABABB11BQ27008371-A453B1AD-51EB-4033-A942-D1941D78696FQ27010018-C0F67A87-ED3D-47A8-BD1A-C27F42177C5DQ27015881-17A9BB9C-1324-4AAC-B3E7-4CBB87BF0907Q27023669-67C097FE-5B29-42F3-97B8-66F70E78C31B
P2860
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Colocalization of inflammatory ...... nce mechanism of immune escape
@ast
Colocalization of inflammatory ...... nce mechanism of immune escape
@en
type
label
Colocalization of inflammatory ...... nce mechanism of immune escape
@ast
Colocalization of inflammatory ...... nce mechanism of immune escape
@en
prefLabel
Colocalization of inflammatory ...... nce mechanism of immune escape
@ast
Colocalization of inflammatory ...... nce mechanism of immune escape
@en
P2093
P2860
P3181
P1476
Colocalization of inflammatory ...... nce mechanism of immune escape
@en
P2093
Alison P Klein
Drew M Pardoll
Geoffrey D Young
Haiying Xu
Janis M Taube
Lieping Chen
Robert A Anders
Shuming Chen
Suzanne L Topalian
Tracee L McMiller
P2860
P304
P3181
P356
10.1126/SCITRANSLMED.3003689
P407
P577
2012-03-01T00:00:00Z